APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells

McCubrey, James AndrewAbrams, Stephen L.Steelman, Linda S.2022-11-082022-11-082022-02-082218-273Xhttp://hdl.handle.net/10342/11719en-USNAX compoundsberberinemutant TP53 reactivatorsAPR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer CellsArticle10.3390/biom12020276